\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ or\\ laboratory\\ test\\ results\\ were\\ not\\ available\\.\\ \\ however\\,\\ these\\ tumors\\ are\\ usually\\ found\\ incidentally\\ on\\ radiographs\\ and\\ usually\\ are\\ asymptomatic\\.\\ \\ typical\\ physical\\ findings\\,\\ when\\ present\\,\\ are\\ a\\ nontender\\ mass\\ that\\ grows\\ slowly\\.\\ \\ when\\ patients\\ develop\\ pain\\,\\ symptoms\\ may\\ result\\ from\\ mass\\ effect\\ of\\ the\\ tumor\\,\\ particularly\\ causing\\ irritation\\ and\\ inflammation\\ of\\ neighboring\\ vessels\\,\\ nerve\\,\\ or\\ bursae\\.\\ pain\\ may\\ also\\ result\\ from\\ malignant\\ transformation\\ to\\ chondrosarcoma\\.\ \(0\)\
\-\ treatment\\ usually\\ involves\\ routine\\ monitoring\\ when\\ tumors\\ do\\ not\\ cause\\ clinical\\ problems\\.\\ \\ if\\ patients\\ develop\\ pain\\,\\ then\\ mr\\ imaging\\ should\\ be\\ done\\ to\\ evaluate\\ for\\ adjacent\\ inflammatory\\ changes\\ such\\ as\\ bursitis\\ and\\ for\\ malignant\\ transformation\\.\\ in\\ adults\\,\\ when\\ the\\ cartilaginous\\ cap\\ measures\\ greater\\ than\\ 1\\ cm\\,\\ the\\ possibility\\ of\\ chondrosarcomatous\\ transformation\\ should\\ be\\ considered\\.\\ in\\ addition\\,\\ \\ contrast\\-enhanced\\ mr\\ imaging\\ may\\ help\\ differentiate\\ \\ the\\ benign\\ osteochondroma\\ \\ \\(enhancement\\ usually\\ only\\ of\\ the\\ fibrovasular\\ tissue\\ around\\ the\\ cartilaginous\\ cap\\)\\ from\\ chondrosarcoma\\.\\ typically\\ with\\ low\\ grade\\ chondrosarcoma\\,\\ fibrovascular\\ tissue\\ between\\ lobules\\ enhances\\ whereas\\ in\\ high\\ grade\\ chondrosarcoma\\ may\\ be\\ more\\ extensive\\.\\ \\ when\\ patients\\ have\\ positive\\ mr\\ imaging\\ findings\\ and\\ \\ clinical\\ symptomatology\\ and\\/or\\ when\\ osteochondromas\\ cause\\ pathologic\\ fractures\\,\\ surgical\\ resection\\ is\\ indicated\\.\ \(0\)\
\-\ radiographs\\ showed\\ an\\ osseous\\ pedunculated\\ mass\\ continuous\\ with\\ and\\ extending\\ from\\ the\\ medullary\\ \\ and\\ cortical\\ bone\\ of\\ the\\ medial\\ tibial\\ metaphysis\\ and\\ pointing\\ away\\ from\\ the\\ joint\\.\\ the\\ mass\\ \\ measures\\ 1\\.1x1\\.16cm\\ \\.\\ \\ stippled\\ calcifications\\ are\\ consistent\\ with\\ the\\ cartilaginous\\ component\\ of\\ the\\ lesion\\.\ \(0\)\
\-\ osteochondroma\ \(97\)\
\-\ 1\\.\\ peripheral\\ osteochondroma\ \(0\)\
\-\ 2\\.\\ peripheral\\ chondrosarcoma\ \(0\)\
\-\ the\\ patient\\ complained\\ of\\ right\\ knee\\ pain\\,\\ was\\ evaluated\\ at\\ the\\ pain\\ clinic\\,\\ and\\ received\\ celecoxib\\ qd\\ for\\ pain\\ with\\ variable\\ results\\.\\ the\\ patient\\ walked\\ into\\ orthopaedics\\ clinic\\ seeking\\ further\\ evaluation\\ and\\ treatment\\ because\\ of\\ continuing\\ pain\\ in\\ the\\ right\\ knee\\ that\\ had\\ not\\ resolved\\ completely\\ with\\ medical\\ management\\.\ \(0\)\
\-\ the\\ characteristic\\ radiographic\\ findings\\ of\\ these\\ tumors\\ \\ are\\ a\\ \\ pedunculated\\ or\\ sessile\\ mass\\ projecting\\ from\\ and\\ continuous\\ with\\ the\\ metaphysis\\ of\\ \\ long\\ bones\\,\\ most\\ frequently\\ the\\ tibia\\,\\ femur\\,\\ or\\ humerus\\.\\ \\ typically\\,\\ these\\ masses\\ point\\ toward\\ the\\ diaphysis\\ and\\ away\\ from\\ the\\ joint\\.\\ axial\\ involvement\\ is\\ less\\ common\\ with\\ single\\ osteochondromas\\ than\\ multiple\\ osteochondromas\\.\\ on\\ the\\ radiographs\\,\\ the\\ cartilaginous\\ cap\\ appears\\ as\\ stippled\\ calcifications\\.\\ mr\\ imaging\\ confirms\\ the\\ \\ tumor\\â\\€\\™s\\ continuity\\ with\\ medullary\\ and\\ cortical\\ bone\\ and\\ shows\\ the\\ high\\-signal\\-intensity\\ cartilaginous\\ cap\\ surrounded\\ by\\ low\\-signal\\-intensity\\ perichondrium\\.\\ \\ osteochondromas\\ are\\ found\\ among\\ all\\ ages\\,\\ although\\ most\\ commonly\\ found\\ in\\ males\\ less\\ than\\ 20\\ years\\ of\\ age\\.\\ \\ most\\ are\\ asymptomatic\\ and\\ found\\ as\\ an\\ incidental\\ finding\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cartilaginous\\:\\ 0\\.06216909199309857\ \(0\)\
\-\ osteochondromas\\:\\ 0\\.05602232285125841\ \(0\)\
\-\ cap\\:\\ 0\\.04941698497941065\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.04843790976980152\ \(0\)\
\-\ osteochondroma\\:\\ 0\\.034543189154307\ \(0\)\
\-\ when\\:\\ 0\\.03329702364103409\ \(0\)\
\-\ transformation\\:\\ 0\\.032960724560642016\ \(0\)\
\-\ stippled\\:\\ 0\\.03268063724050974\ \(0\)\
\-\ mr\\:\\ 0\\.024627659609491467\ \(0\)\
\-\ pedunculated\\:\\ 0\\.024554743956028764\ \(0\)\
\-\ found\\:\\ 0\\.02442653618550669\ \(0\)\
\-\ usually\\:\\ 0\\.023536764207408245\ \(0\)\
\-\ continuous\\:\\ 0\\.022715899928327343\ \(0\)\
\-\ away\\:\\ 0\\.022518688536310387\ \(0\)\
\-\ tumors\\:\\ 0\\.021834805154221093\ \(0\)\
\-\ from\\:\\ 0\\.02010215417705099\ \(0\)\
\-\ chondrosarcomatous\\:\\ 0\\.019989837696069157\ \(0\)\
\-\ fibrovasular\\:\\ 0\\.019989837696069157\ \(0\)\
\-\ 1\\.1x1\\.16cm\\:\\ 0\\.019989837696069157\ \(0\)\
\-\ celecoxib\\:\\ 0\\.019989837696069157\ \(0\)\
\-\ develop\\:\\ 0\\.019327172482385295\ \(0\)\
\-\ metaphysis\\:\\ 0\\.01927968359409824\ \(0\)\
\-\ medullary\\:\\ 0\\.01862126178074451\ \(0\)\
\-\ are\\:\\ 0\\.018490061468723836\ \(0\)\
\-\ perichondrium\\:\\ 0\\.01841807538187427\ \(0\)\
\-\ radiographs\\:\\ 0\\.01841000572246349\ \(0\)\
\-\ imaging\\:\\ 0\\.018159399768304788\ \(0\)\
\-\ clinic\\:\\ 0\\.01731658118005616\ \(0\)\
\-\ may\\:\\ 0\\.017000710829007927\ \(0\)\
\-\ measures\\:\\ 0\\.01658259920522435\ \(0\)\
\-\ pain\\:\\ 0\\.01656520900842436\ \(0\)\
\-\ neighboring\\:\\ 0\\.01634031862025487\ \(0\)\
\-\ bursae\\:\\ 0\\.01634031862025487\ \(0\)\
\-\ fibrovascular\\:\\ 0\\.01634031862025487\ \(0\)\
\-\ results\\:\\ 0\\.01564418326051994\ \(0\)\
\-\ lobules\\:\\ 0\\.01557734302700949\ \(0\)\
\-\ walked\\:\\ 0\\.01557734302700949\ \(0\)\
\-\ seeking\\:\\ 0\\.01557734302700949\ \(0\)\
\-\ than\\:\\ 0\\.015231624863389618\ \(0\)\
\-\ these\\:\\ 0\\.015128195183386666\ \(0\)\
\-\ patients\\:\\ 0\\.015044725165755278\ \(0\)\
\-\ orthopaedics\\:\\ 0\\.015007469039977956\ \(0\)\
\-\ result\\:\\ 0\\.014867048330829758\ \(0\)\
\-\ grade\\:\\ 0\\.014761164593881953\ \(0\)\
\-\ low\\-signal\\-intensity\\:\\ 0\\.014552433449360833\ \(0\)\
\-\ calcifications\\:\\ 0\\.014408905916701825\ \(0\)\
\-\ grows\\:\\ 0\\.014355128739633781\ \(0\)\
\-\ high\\-signal\\-intensity\\:\\ 0\\.014173626001145037\ \(0\)\
\-\ cortical\\:\\ 0\\.014127323585377832\ \(0\)\
\-\ knee\\:\\ 0\\.01405211212045477\ \(0\)\
\-\ peripheral\\:\\ 0\\.014022373342467653\ \(0\)\
\-\ malignant\\:\\ 0\\.014007576763624949\ \(0\)\
\-\ pointing\\:\\ 0\\.014005580712814603\ \(0\)\
\-\ sessile\\:\\ 0\\.013702788439289607\ \(0\)\
\-\ typically\\:\\ 0\\.01367993546261212\ \(0\)\
\-\ mass\\:\\ 0\\.013474614591242228\ \(0\)\
\-\ bursitis\\:\\ 0\\.01343570672578307\ \(0\)\
\-\ most\\:\\ 0\\.013420647222639973\ \(0\)\
\-\ less\\:\\ 0\\.013124444464048446\ \(0\)\
\-\ cause\\:\\ 0\\.013112302161233406\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.013100192281161395\ \(0\)\
\-\ irritation\\:\\ 0\\.013086158698963889\ \(0\)\
\-\ continuing\\:\\ 0\\.012980671135165947\ \(0\)\
\-\ \\,\\:\\ 0\\.012890955500823208\ \(0\)\
\-\ qd\\:\\ 0\\.012783366425438893\ \(0\)\
\-\ joint\\:\\ 0\\.012532558979782681\ \(0\)\
\-\ symptomatology\\:\\ 0\\.012516284711932358\ \(0\)\
\-\ findings\\:\\ 0\\.012373040379523534\ \(0\)\
\-\ should\\:\\ 0\\.012354687264801814\ \(0\)\
\-\ clinical\\:\\ 0\\.011924307483292537\ \(0\)\
\-\ continuity\\:\\ 0\\.011801815218417853\ \(0\)\
\-\ projecting\\:\\ 0\\.011625031677670207\ \(0\)\
\-\ whereas\\:\\ 0\\.011514396384769001\ \(0\)\
\-\ among\\:\\ 0\\.011514396384769001\ \(0\)\
\-\ differentiate\\:\\ 0\\.011408908820971059\ \(0\)\
\-\ males\\:\\ 0\\.011164848357949822\ \(0\)\
\-\ surrounded\\:\\ 0\\.011074133313474314\ \(0\)\
\-\ toward\\:\\ 0\\.011030101372755261\ \(0\)\
\-\ ages\\:\\ 0\\.010986908186880672\ \(0\)\
\-\ contrast\\-enhanced\\:\\ 0\\.010862056084424827\ \(0\)\
\-\ monitoring\\:\\ 0\\.010705609663819497\ \(0\)\
\-\ slowly\\:\\ 0\\.01052410692533075\ \(0\)\
\-\ diaphysis\\:\\ 0\\.01042179301313014\ \(0\)\
\-\ variable\\:\\ 0\\.010323896931803135\ \(0\)\
\-\ confirms\\:\\ 0\\.010292182097393295\ \(0\)\
\-\ complained\\:\\ 0\\.010230052904222967\ \(0\)\
\-\ particularly\\:\\ 0\\.009997277044676293\ \(0\)\
\-\ humerus\\:\\ 0\\.009969790966371656\ \(0\)\
\-\ nontender\\:\\ 0\\.009942634070574113\ \(0\)\
\-\ adults\\:\\ 0\\.009889276933589547\ \(0\)\
\-\ possibility\\:\\ 0\\.009786187649968784\ \(0\)\
\-\ help\\:\\ 0\\.009663586241192648\ \(0\)\
\-\ bone\\:\\ 0\\.009630089258321406\ \(0\)\
\-\ physical\\:\\ 0\\.009507960406264119\ \(0\)\
\-\ resolved\\:\\ 0\\.009393853944454857\ \(0\)\
\-\ completely\\:\\ 0\\.009310630890372255\ \(0\)\
\-\ tissue\\:\\ 0\\.009185583621100198\ \(0\)\
\-\ enhances\\:\\ 0\\.009152822972460247\ \(0\)\
\-\ or\\:\\ 0\\.009084106566564241\ \(0\)\
\-\ tumor\\:\\ 0\\.009035067127486673\ \(0\)\
\-\ involves\\:\\ 0\\.009005286479609766\ \(0\)\
\-\ received\\:\\ 0\\.009005286479609766\ \(0\)\
\-\ problems\\:\\ 0\\.008969854919738835\ \(0\)\
\-\ be\\:\\ 0\\.008964331451319245\ \(0\)\
\-\ tibial\\:\\ 0\\.008952344611135863\ \(0\)\
\-\ tibia\\:\\ 0\\.008900610647947267\ \(0\)\
\-\ evaluated\\:\\ 0\\.008883624997767771\ \(0\)\
\-\ component\\:\\ 0\\.008850030698935253\ \(0\)\
\-\ as\\:\\ 0\\.008793044257783182\ \(0\)\
\-\ incidentally\\:\\ 0\\.008784299322805429\ \(0\)\
\-\ pathologic\\:\\ 0\\.008481507049280433\ \(0\)\
\-\ point\\:\\ 0\\.008467378818553369\ \(0\)\
\-\ do\\:\\ 0\\.008411730045500948\ \(0\)\
\-\ not\\:\\ 0\\.008400127018652621\ \(0\)\
\-\ frequently\\:\\ 0\\.00839802865217677\ \(0\)\
\-\ indicated\\:\\ 0\\.008384409549999418\ \(0\)\
\-\ causing\\:\\ 0\\.008370871756379227\ \(0\)\
\-\ femur\\:\\ 0\\.008370871756379227\ \(0\)\
\-\ test\\:\\ 0\\.008278304875380917\ \(0\)\
\-\ inflammation\\:\\ 0\\.008239761618309327\ \(0\)\
\-\ osseous\\:\\ 0\\.008227058090988079\ \(0\)\
\-\ addition\\:\\ 0\\.008214425335773896\ \(0\)\
\-\ characteristic\\:\\ 0\\.008201862568482252\ \(0\)\
\-\ and\\/or\\:\\ 0\\.008189369017890483\ \(0\)\
\-\ bones\\:\\ 0\\.00817694392545369\ \(0\)\
\-\ around\\:\\ 0\\.008068079482854233\ \(0\)\
\-\ done\\:\\ 0\\.008032922597285152\ \(0\)\
\-\ single\\:\\ 0\\.007854104967098485\ \(0\)\
\-\ treatment\\:\\ 0\\.007844067843994953\ \(0\)\
\-\ the\\:\\ 0\\.00783726103762051\ \(0\)\
\-\ evaluate\\:\\ 0\\.007832712603757536\ \(0\)\
\-\ considered\\:\\ 0\\.00782209163025997\ \(0\)\
\-\ vessels\\:\\ 0\\.007800997769347694\ \(0\)\
\-\ typical\\:\\ 0\\.007769720394897954\ \(0\)\
\-\ routine\\:\\ 0\\.007769720394897954\ \(0\)\
\-\ extensive\\:\\ 0\\.007749105946595795\ \(0\)\
\-\ radiographic\\:\\ 0\\.0073545677818338635\ \(0\)\
\-\ fractures\\:\\ 0\\.007337389111066385\ \(0\)\
\-\ incidental\\:\\ 0\\.007337389111066385\ \(0\)\
\-\ management\\:\\ 0\\.007311862683572883\ \(0\)\
\-\ commonly\\:\\ 0\\.007311862683572883\ \(0\)\
\-\ greater\\:\\ 0\\.0072782683847403655\ \(0\)\
\-\ appears\\:\\ 0\\.007212537008610541\ \(0\)\
\-\ laboratory\\:\\ 0\\.007140797586970672\ \(0\)\
\-\ involvement\\:\\ 0\\.0071019017157093346\ \(0\)\
\-\ nerve\\:\\ 0\\.006981737248270536\ \(0\)\
\-\ 20\\:\\ 0\\.006967154730514775\ \(0\)\
\-\ then\\:\\ 0\\.006895616504358481\ \(0\)\
\-\ effect\\:\\ 0\\.006860676310814614\ \(0\)\
\-\ because\\:\\ 0\\.006778953098834576\ \(0\)\
\-\ inflammatory\\:\\ 0\\.006719537288417288\ \(0\)\
\-\ that\\:\\ 0\\.00669379015219421\ \(0\)\
\-\ benign\\:\\ 0\\.0066871890408916135\ \(0\)\
\-\ long\\:\\ 0\\.006680774400981233\ \(0\)\
\-\ masses\\:\\ 0\\.006550096140580697\ \(0\)\
\-\ although\\:\\ 0\\.00654405732557053\ \(0\)\
\-\ available\\:\\ 0\\.006514102151564166\ \(0\)\
\-\ extending\\:\\ 0\\.006514102151564166\ \(0\)\
\-\ showed\\:\\ 0\\.006353295392117226\ \(0\)\
\-\ positive\\:\\ 0\\.0062877224269481105\ \(0\)\
\-\ finding\\:\\ 0\\.006245037426391114\ \(0\)\
\-\ medial\\:\\ 0\\.006197958080703066\ \(0\)\
\-\ 2\\.\\:\\ 0\\.006162004856689928\ \(0\)\
\-\ further\\:\\ 0\\.006162004856689928\ \(0\)\
\-\ between\\:\\ 0\\.0061417132340685805\ \(0\)\
\-\ adjacent\\:\\ 0\\.006126612798490401\ \(0\)\
\-\ such\\:\\ 0\\.0060574439678930895\ \(0\)\
\-\ 1\\.\\:\\ 0\\.006052583143531975\ \(0\)\
\-\ resection\\:\\ 0\\.006042892642902991\ \(0\)\
\-\ medical\\:\\ 0\\.005962153741646268\ \(0\)\
\-\ age\\:\\ 0\\.005897755840236523\ \(0\)\
\-\ only\\:\\ 0\\.0058263302913490606\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.005791443854071329\ \(0\)\
\-\ and\\:\\ 0\\.0057145716105466175\ \(0\)\
\-\ years\\:\\ 0\\.005689893734735788\ \(0\)\
\-\ evaluation\\:\\ 0\\.005628659400967818\ \(0\)\
\-\ s\\:\\ 0\\.005557296297311989\ \(0\)\
\-\ changes\\:\\ 0\\.005553396771508074\ \(0\)\
\-\ axial\\:\\ 0\\.005530139401514448\ \(0\)\
\-\ all\\:\\ 0\\.005480552130229684\ \(0\)\
\-\ however\\:\\ 0\\.005395392416319888\ \(0\)\
\-\ low\\:\\ 0\\.005388136174300226\ \(0\)\
\-\ an\\:\\ 0\\.005359024327821904\ \(0\)\
\-\ shows\\:\\ 0\\.00532737800392036\ \(0\)\
\-\ high\\:\\ 0\\.005302825535321578\ \(0\)\
\-\ if\\:\\ 0\\.005257921618550194\ \(0\)\
\-\ cm\\:\\ 0\\.005197179405480694\ \(0\)\
\-\ enhancement\\:\\ 0\\.005193852077376499\ \(0\)\
\-\ common\\:\\ 0\\.005070900707384121\ \(0\)\
\-\ for\\:\\ 0\\.004959919378521871\ \(0\)\
\-\ more\\:\\ 0\\.004846204783020785\ \(0\)\
\-\ symptoms\\:\\ 0\\.004829155276413014\ \(0\)\
\-\ in\\:\\ 0\\.004777746373472278\ \(0\)\
\-\ consistent\\:\\ 0\\.004751243239980053\ \(0\)\
\-\ 1\\:\\ 0\\.004610717387663735\ \(0\)\
\-\ into\\:\\ 0\\.004610717387663735\ \(0\)\
\-\ were\\:\\ 0\\.004399742260067849\ \(0\)\
\-\ present\\:\\ 0\\.004376437083745308\ \(0\)\
\-\ exam\\:\\ 0\\.004256766303740449\ \(0\)\
\-\ have\\:\\ 0\\.004196004712846013\ \(0\)\
\-\ had\\:\\ 0\\.004181065349752173\ \(0\)\
\-\ right\\:\\ 0\\.004089032694378307\ \(0\)\
\-\ multiple\\:\\ 0\\.004081192751653671\ \(0\)\
\-\ surgical\\:\\ 0\\.0040730652386654275\ \(0\)\
\-\ lesion\\:\\ 0\\.003946837247166564\ \(0\)\
\-\ patient\\:\\ 0\\.0038847706617523266\ \(0\)\
\-\ also\\:\\ 0\\.0038199990786171234\ \(0\)\
\-\ on\\:\\ 0\\.0032829524370314197\ \(0\)\
\-\ by\\:\\ 0\\.003226464633208333\ \(0\)\
\-\ of\\:\\ 0\\.0029059904960949496\ \(0\)\
\-\ at\\:\\ 0\\.002625313271727059\ \(0\)\
\-\ is\\:\\ 0\\.002550071557300343\ \(0\)\
\-\ was\\:\\ 0\\.0022409921138632355\ \(0\)\
\-\ with\\:\\ 0\\.0021225247363245306\ \(0\)\
\-\ to\\:\\ 0\\.0019368168183355387\ \(0\)\
\-\ \\.\\:\\ 0\\.0018514497284330257\ \(0\)\
\-\ a\\:\\ 0\\.0017986385570004594\ \(0\)\
\-\ \\(\\:\\ 0\\.0016380084495325636\ \(0\)\
\-\ \\)\\:\\ 0\\.0016179993018442293\ \(0\)\
